loading page

Nephrin in maternal urine applied to a point-of-care kit to predict preeclampsia: a prospective study.
  • +6
  • Kyong-No Lee,
  • Subeen Hong,
  • Tae Eun Kim,
  • Eun Ji Oh,
  • Ki-seok Kim,
  • Ju-Hyung Kang,
  • Min-Young Yeo,
  • Hyeon Ji Kim,
  • Jee Yoon Park
Kyong-No Lee
Seoul National University Bundang Hospital Department of Obstetrics and Gynecology
Author Profile
Subeen Hong
Catholic University of Korea School of Medicine
Author Profile
Tae Eun Kim
Seoul National University Bundang Hospital
Author Profile
Eun Ji Oh
Seoul National University Bundang Hospital Department of Obstetrics and Gynecology
Author Profile
Ki-seok Kim
Aptamer Sciences Inc
Author Profile
Ju-Hyung Kang
Aptamer Sciences Inc
Author Profile
Min-Young Yeo
Aptamer Sciences Inc
Author Profile
Hyeon Ji Kim
Seoul National University Bundang Hospital Department of Obstetrics and Gynecology
Author Profile
Jee Yoon Park
Seoul National University Bundang Hospital

Corresponding Author:[email protected]

Author Profile

Abstract

Objective: Nephrin is a protein in the glomerular podocyte slit diaphragm; therefore, its presence in urine implies damage to podocytes. This study aimed to determine the efficacy of nephrin as a biomarker in maternal urine to predict preeclampsia (PE). Design and setting: This prospective study included pregnant women admitted for delivery at Seoul National University Bundang Hospital: March 2019 – May 2020. Population: Patients who had been diagnosed with PE were included and patients without a history of underlying diseases were recruited for the control group. Important clinical data has been collected. Methods: Urine samples were obtained, and nephrin signaling was detected through test strips using a lateral flow assay. Main Outcome Measures: The results of the point-of-care test were compared between the 2 groups: patients with PE, and without (control group) using the exact concentration of nephrin by enzyme-linked immunosorbent assay (ELISA). Results: Clinical characteristics – maternal age, rate of nulliparity, proportion of twin pregnancies, height, weight, cesarean section rate – were comparable between the PE and control groups. Nephrin signals were classified into four groups. In the PE group, signals 0, 1, 2, and 3 were found in 18.4% (9/49), 44.9% (22/49), 24.5% (12/49), and 12.2% (6/49) of participants, respectively. This was significantly different from the control group, in which 84.3% (43/51) were found to have signal 0 (P<0.001). Conclusions: Nephrin signaling in maternal urine could be a noninvasive and useful test for predetecting severity of PE.